According to the research report titled ‘Prurigo Nodularis Treatment Market Size By Product (Antihistamines, Capsaicin Cream, Corticosteroids, Emollients), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, global prurigo nodularis treatment market is anticipated to grow momentously through 2027.
 

Increasing demand for better medication, rising adoption of antihistamines, growing investments in research & development of innovative products are the factors driving the growth of global prurigo nodularis treatment market.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793265/
 

For the unversed, prurigo nodularis is a skin disease in which hard itchy lumps are formed on the skin. These bumps can vary in size from very small to over half an inch in diameter and can range from 2 to 200 in numbers.
 

However, no approved targeted drugs or therapies is acting as a major restraint for global prurigo nodularis treatment market outlook.
 

Based on product type, prurigo nodularis treatment industry is segmented into emollients, capsaicin cream, antihistamines, and corticosteroids among others.  As per the report, antihistamines segment is poised to grow at 5.1% CAGR over the forecast duration, owing to high adoption of these drugs for first line therapy in managing allergies.
 

Speaking of distribution channel, the overall industry is divided into hospitals pharmacies, online pharmacies, and retail pharmacies. Among these, hospital pharmacies held a share of over 27.5% in 2020 and is expected to bolster over the forecast timeline, due to rising demand for better medication, along with high patient pool in hospitals.
 

As per regional framework, North America prurigo nodularis treatment market is expected to grow significantly between 2021 and 2027, owing to rising investments in research & development, growing demand for innovative drugs, and launch of innovative therapies by local players in the United States.
 

Leading players in worldwide prurigo nodularis treatment market include Galderma S.A., Bayer AG, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Sanofi S.A., Merck & Co. Inc., Pfizer Inc., and Johnson & Johnson Services Inc.